Somerset Pharmaceuticals, Inc.
Records under this name other than patents Somerset Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Somerset Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,239,181 | Method for preventing and treating peripheral neurophathy by administering selegiline Lapsed on the fee record Ended May 29, 2013 · USPTO record | Lapsed on the fee record | Ended May 29, 2013 | USPTO record |
| US 6,210,706 | S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions Lapsed on the fee record Ended Apr 3, 2013 · USPTO record | Lapsed on the fee record | Ended Apr 3, 2013 | USPTO record |
| US 6,117,912 | Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions Lapsed on the fee record Ended Sep 12, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | USPTO record |
| US 6,759,053 | S(+) Desmethylselegiline and Its Use to Treat Adhd Lapsed on the fee record Ended Jul 6, 2012 · Low confidence | Lapsed on the fee record | Ended Jul 6, 2012 | Low confidence |
| US 6,743,824 | Method for Preventing and Treating Peripheral Neuropathy by Administering Selegiline No holder on record Lapsed on the fee record Ended Jun 1, 2012 · Medium confidence | Lapsed on the fee record | Ended Jun 1, 2012 | Medium confidence |
| US 6,709,664 | Methods for Treating Photodamaged Skin by Administering Selegiline or Desmethylselegiline No holder on record Lapsed on the fee record Ended Mar 23, 2012 · Low confidence | Lapsed on the fee record | Ended Mar 23, 2012 | Low confidence |
| US 6,033,682 | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions Lapsed on the fee record Ended Mar 7, 2012 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2012 | USPTO record |
| US 6,699,495 | Methods for treating multiple sclerosis employing desmethylselegiline Lapsed on the fee record Ended Mar 2, 2012 · USPTO record | Lapsed on the fee record | Ended Mar 2, 2012 | USPTO record |
| US 6,562,364 | Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms Lapsed on the fee record Ended May 13, 2011 · USPTO record | Lapsed on the fee record | Ended May 13, 2011 | USPTO record |
| US 6,562,365 | Methods employing R(−)-desmethylselegiline Lapsed on the fee record Ended May 13, 2011 · USPTO record | Lapsed on the fee record | Ended May 13, 2011 | USPTO record |